Mode
Text Size
Log in / Sign up

GSTM1 and GSTT1 null genotype frequencies in 300 healthy individuals from urban Venezuela.

GSTM1 and GSTT1 null genotype frequencies in 300 healthy individuals from urban Venezuela.
Photo by Navy Medicine / Unsplash
Key Takeaway
Note the GSTM1 (38.67%) and GSTT1 (32.67%) null genotype frequencies in this urban Venezuelan cohort.

This cross-sectional descriptive study evaluated the prevalence of GSTM1 and GSTT1 null genotypes among 300 healthy unrelated individuals residing in an urban area of Venezuela. The intervention or exposure involved genotyping for these specific null polymorphisms, with regional and global reference data serving as the comparator context.

The primary outcome measured the frequency of these genetic variants. The study reported a GSTM1 null genotype frequency of 38.67%, a GSTT1 null genotype frequency of 32.67%, and a double null genotype frequency of 6.00%. No secondary outcomes were reported, and no adverse events, serious adverse events, discontinuations, or tolerability data were collected or reported.

Key limitations include the cross-sectional design, which precludes causal inference, and the lack of reported p-values or confidence intervals for the observed frequencies. The study provides an updated genetic baseline for the urban cohort and a descriptive framework for future toxicogenomic research and personalized medicine applications, though it does not inform clinical management of specific conditions.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
IntroductionThe Glutathione S-Transferase (GST) family consists of enzymes with widely studied genetic polymorphisms. Current documentation of GST variant distribution across Venezuelan regions is fragmented. This study aims to determine the prevalence of GSTM1 and GSTT1 null genotypes in a healthy urban Venezuelan group and to compare these frequencies with regional and global reference data.MethodsA cross-sectional descriptive study was conducted on 300 healthy unrelated individuals. Genotyping was performed via multiplex PCR, and frequencies were calculated based on the presence or absence of specific amplicons.ResultsThe frequencies of the GSTM1 and GSTT1 null genotypes were 38.67% and 32.67%, respectively. The “double null” genotype was observed in 6.00% of the sample, representing a relevant ethnogeographic heterogeneity.DiscussionComparative analysis revealed a divergence from reported data for ancestral Amerindian groups and an allelic distribution pattern reflecting a tri-hybrid genetic architecture intermediate between West African and Southern European references. These findings establish an updated genetic baseline for this urban cohort, highlighting a distinct genotypic distribution within the Venezuelan population. This study underscores the degree of population stratification in the region and provides a descriptive framework for future toxicogenomic research and personalized medicine applications.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.